Sai Krishna

Michael Owen Joins ehamarkets as Global Brand Ambassador

HONG KONG and NEW YORK, Aug. 14, 2026 /PRNewswire/ — ehamarkets today announced a global brand partnership with England football legend and 2001 Ballon d’Or winner Michael Owen, who has joined the brand as its Global Brand Ambassador. Owen said he was drawn to ehamarkets’ focus on technology, reliability and a simpler trading experience. “I’m […]

Michael Owen Joins ehamarkets as Global Brand Ambassador Read More »

FERRERO GROUP TO ACQUIRE PURELY ELIZABETH, A LEADING U.S. MODERN WELLNESS BRAND

LUXEMBOURG and BOULDER, Colo., Aug. 14, 2026 /PRNewswire/ — Ferrero Group today announced it has signed an agreement to acquire Purely Elizabeth, the high-growth modern wellness brand and a leading better-for-you food company based in the U.S. The acquisition further enhances Ferrero’s relevance at the American breakfast table with Purely Elizabeth joining its portfolio. Following closing,

FERRERO GROUP TO ACQUIRE PURELY ELIZABETH, A LEADING U.S. MODERN WELLNESS BRAND Read More »

Bybit TradFi Perpetuals Extend 24/7 Exposure to Over 200 Global Equities and Pre-IPO Assets

DUBAI, UAE, Aug. 14, 2026 /PRNewswire/ — Bybit, the world’s second-largest cryptocurrency exchange by trading volume, is pleased to announce TradFi Perpetual Contracts now offer over 200 curated TradFi-themed listings, marking one of the highest quality coverage of TradFi derivatives exposure available on a crypto-native platform. The lineup now spans equities, ETFs, precious metals, indices,

Bybit TradFi Perpetuals Extend 24/7 Exposure to Over 200 Global Equities and Pre-IPO Assets Read More »

RemotePeople Completes 2026 SOC 2 Type II Audit Across Security, Availability, and Confidentiality

The New York-headquartered global Employer of Record renews its SOC 2 Type II attestation for a full 12-month period, adding to its ISO 27001 and GDPR certifications and its recent A+ platform security rating from Astra Security. NEW YORK, Aug. 14, 2026 /PRNewswire/ — RemotePeople, a global provider of Employer of Record (EOR), payroll, and

RemotePeople Completes 2026 SOC 2 Type II Audit Across Security, Availability, and Confidentiality Read More »

Hippocratic AI Unveils Agentic Orchestrators: NYSE Content Update

NYSE issues a pre-market daily advisory direct from the trading floor. NEW YORK, Aug. 14, 2026 /PRNewswire/ — The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the NYSE Trading Floor. Access today’s NYSE Pre-market update for market insights before trading begins.  Kristen Scholer delivers the pre-market update on August 14th

Hippocratic AI Unveils Agentic Orchestrators: NYSE Content Update Read More »

Fractal’s Vaidya.ai Powers BMC Health AI Chatbot on WhatsApp for Mumbai

First deployment under the MoU with BMC to pioneer integrated AI solutions spanning patient interactions, doctor support, and public health intelligence MUMBAI, India, Aug. 14, 2026 /PRNewswire/ — Fractal Analytics Ltd. (BSE: 544700) (NSE: FRACTAL), a globally recognized enterprise AI company serving Fortune 500® organizations, today announced launch of the beta version of BMC Health AI Chatbot

Fractal’s Vaidya.ai Powers BMC Health AI Chatbot on WhatsApp for Mumbai Read More »

Bitmine Immersion Technologies Announces Record and Payment Dates for Cash Dividends on 9.50% Series A Perpetual Preferred Stock

NORWALK, Conn., Aug. 14, 2026 /PRNewswire/ — (NYSE: BMNR; BMNP) Bitmine Immersion Technologies, Inc. (“Bitmine” or the “Company”) announced today that its Board of Directors has declared seventeen cash dividends on the Company’s 9.50% Series A Perpetual Preferred Stock (the “Series A Preferred Stock”), which is listed on the New York Stock Exchange under the

Bitmine Immersion Technologies Announces Record and Payment Dates for Cash Dividends on 9.50% Series A Perpetual Preferred Stock Read More »

ArkBio’s RSV Antiviral Drug Ziresovir Receives FDA Approval for Phase II Clinical Trial

SHANGHAI, Aug. 14, 2026 /PRNewswire/ — Shanghai Ark Biopharmaceutical Co., Ltd. (“ArkBio”) today announced that the U.S. Food and Drug Administration (FDA) has approved ziresovir (AK0529) for a phase II clinical trial in the severely ill RSV infected infant patients, including the ones in pediatric intensive care unit (PICU). Severe RSV Infection: An Urgent Unmet Need

ArkBio’s RSV Antiviral Drug Ziresovir Receives FDA Approval for Phase II Clinical Trial Read More »

AXISCADES reports record Rs. 346.7 crore revenue from operations for Q1 FY27, including discontinued operations, up 42.2% YoY

Defence and XiDA drive retained portfolio growth BENGALURU, India, Aug. 14, 2026 /PRNewswire/ — AXISCADES Technologies Limited (BSE: 532395) (NSE: AXISCADES), a technology, engineering and manufacturing company focused on Aerospace, Defence, Space and XiDA/electronics and AI, today announced its consolidated results for the quarter ended 30 June 2026. Q1 FY27 consolidated revenue from operations, comprising continuing

AXISCADES reports record Rs. 346.7 crore revenue from operations for Q1 FY27, including discontinued operations, up 42.2% YoY Read More »

Nava Sets New Quarterly High with Total Income of ₹1,269 Crore

HYDERABAD, India, Aug. 14, 2026 /PRNewswire/ — Nava Limited today announced its financial results for the quarter-ended June 30, 2026, reporting its highest-ever quarterly total income, while standalone PBT before exceptional items rose 92.9% QoQ, supported by lower material and manufacturing costs and dividend income. Key Highlights Record Performance: Consolidated total income stood at ₹1,269 crore,

Nava Sets New Quarterly High with Total Income of ₹1,269 Crore Read More »